STOCK TITAN

Guardian Pharmacy executive converts 18,931 shares

The reported 53,057-share Class A balance excludes 21,343 shares Crisafulli agreed to transfer under a domestic relations order.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. reported that Senior Vice President, Payor and Industry Strategy Chris Crisafulli's 18,931 shares of Class B common stock automatically converted into 18,931 shares of Class A common stock on September 27, 2026, on a one-for-one basis under its Amended and Restated Certificate of Incorporation. Crisafulli directly held 53,057 Class A shares following the conversion.

Insider Crisafulli Chris
Role See Remarks
Type Security Shares Price Value
Exercise Class B Common Stock F1 18,931 -- --
Exercise Class A Common Stock F1, F2 18,931 -- --
Holdings After Transaction: Class B Common Stock — 0 contracts (Direct); Class A Common Stock — 53,057 shares (Direct)
Footnotes (2)
  1. F1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
  2. F2. Excludes 21,343 shares of Class A common stock that the Reporting Person has agreed to transfer pursuant to a domestic relations order relating to an existing divorce settlement agreement with the Reporting Person's former spouse.
Class B shares converted 18,931 shares Automatic conversion on September 27, 2026
Class A shares acquired 18,931 shares Automatic conversion on September 27, 2026
Class A shares after conversion 53,057 shares Direct holdings following conversion
Class A shares agreed to transfer 21,343 shares Pursuant to a domestic relations order
Amended and Restated Certificate of Incorporation technical
"Pursuant to Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
one-for-one basis financial
"converted into shares of the Issuer's Class A common stock, on a one-for-one basis"
domestic relations order regulatory
"agreed to transfer pursuant to a domestic relations order"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GRDN shares did Chris Crisafulli convert?

Chris Crisafulli's 18,931 Class B shares automatically converted into 18,931 Class A shares on September 27, 2026, on a one-for-one basis under Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation.

How many Class A shares did Chris Crisafulli hold after the GRDN conversion?

Chris Crisafulli directly held 53,057 Class A shares after the conversion. The reported balance excludes 21,343 Class A shares he agreed to transfer pursuant to a domestic relations order relating to an existing divorce settlement agreement with his former spouse.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Crisafulli Chris

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/27/2026M18,931A(1)53,057(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock(1)09/27/2026M18,931 (1) (1)Class A Common Stock18,931(1)0D
Explanation of Responses:
1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
2. Excludes 21,343 shares of Class A common stock that the Reporting Person has agreed to transfer pursuant to a domestic relations order relating to an existing divorce settlement agreement with the Reporting Person's former spouse.
Remarks:
Senior Vice President, Payor and Industry Strategy
/s/ Douglas Towns, Attorney-in-Fact09/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading